UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): July 25, 2007
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
000-29823 |
|
74-2793174 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
of Incorporation) |
|
|
|
Identification No.) |
400 West Cesar Chavez, Austin, TX 78701
(Address of Principal Executive Offices) (Zip Code)
Registrants telephone number, including area code: (512) 416-8500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition
On July 25, 2007, Silicon Laboratories Inc. (Silicon Laboratories) issued a press release describing its results of operations for its fiscal quarter ended June 30, 2007. A copy of the press release is attached as Exhibit 99 to this report.
Item 8.01. Other Events
On July 25, 2007, Silicon Laboratories also announced in its press release that its Board of Directors authorized a new share repurchase program having an aggregate value of up to $400 million over a period of 24 months.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
99 Press Release of Silicon Laboratories Inc. dated July 25, 2007.
Use of Non-GAAP Financial Information
From time to time, Silicon Laboratories provides certain non-GAAP financial measures as additional information relating to its operating results. The non-GAAP financial measurements provided in the press release furnished herewith do not replace the presentation of Silicon Laboratories GAAP financial results. These additional measurements merely provide supplemental information to assist investors in analyzing Silicon Laboratories financial position and results of operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures used by other companies. Silicon Laboratories has chosen to provide this information to investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future operating results, and as a means to highlight the results of core ongoing operations.
Pursuant to the requirements of Regulation G, we have provided in the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures.
The information in this report, including the exhibit hereto, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. The information contained therein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
SILICON LABORATORIES INC. |
|
|
|
|
|
|
|
July 25, 2007 |
|
/s/Paul V. Walsh, Jr. |
Date |
|
Paul V. Walsh,
Jr. |
3
EXHIBIT INDEX
Exhibit No. |
|
Description |
|
99 |
|
Press release dated July 25, 2007 of the Registrant |
4
Exhibit 99
SILICON LABORATORIES ANNOUNCES RECORD REVENUE
Company Also Announces Significant Expansion of Share Repurchase Program
AUSTIN, Texas July 25, 2007 Silicon Laboratories Inc. (Nasdaq: SLAB), a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported record revenue in continuing operations of $75.6 million and earnings per share results that exceeded the companys guidance. The company also announced a significant increase in the share repurchase program.
Share Repurchase Program
Silicon Laboratories Board of Directors approved a new $400 million share repurchase plan, quadrupling the previous authorization. The program will be executed on the open market or in private transactions, including structured or accelerated transactions, depending on market conditions.
It is our intention to be active in the execution of this program, effectively returning capital to shareholders and significantly reducing our outstanding share base, said Bill Bock, chief financial officer of Silicon Laboratories. We also believe this is a responsible action relative to our cash position in that it returns value to shareholders while retaining our financial flexibility for either the operation of the business or for strategic opportunities.
Second Quarter Financial Results
Revenue increased by two percent year over year to record levels in the second quarter. GAAP gross margin totaled 60 percent. GAAP operating income was $1.9 million. GAAP diluted earnings per share from continuing operations of $0.12 represented more than a 100 percent improvement over the same period last year.
Excluding an $8.6 million charge for stock compensation expense, non-GAAP operating income was $10.6 million or 14 percent of revenue, representing significant progress towards the companys target model. Non-GAAP diluted earnings per share from continuing operations totaled $0.26, an increase of 60 percent sequentially. The reconciling charges are set forth in the financial measures table included below.
The company ended the quarter with approximately $644 million in cash, cash equivalents and short-term investments.
Business Summary
During the second quarter, growth was driven by strength in the broadcast and microcontroller product lines. Strong demand from certain handset customers and increasing diversification in non-handset applications resulted in a double-digit broadcast revenue increase. The company also began to ship its new FM transmitter in the second quarter as planned.
The MCU business continued to grow across consumer, industrial and networking applications. The company believes that recent new product introductions and future products under development as part of the MCU roadmap will significantly expand the companys served available market over time.
We believe that improved visibility into the next two quarters and current business trends support the companys annual growth targets, said Necip Sayiner, president and chief executive officer of Silicon Laboratories. The margin leverage in our new business model will really become impactful as we grow our revenue in the second half of the year.
For the third quarter of 2007, the company believes revenue in all of its core product lines will experience growth and is guiding revenue in the range of $81 to $84 million.
Webcast and Conference Call
A conference call discussing the second quarter results will follow this press release today at 7:30 a.m. Central Time. An audio webcast will be available simultaneously on Silicon Laboratories website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 888-568-0091 or +1 402-530-7778 (international). Replays will be available through August 8, 2007.
About Silicon Laboratories Inc.
Silicon Laboratories Inc. is a leading designer of high-performance, analog-intensive, mixed-signal integrated circuits (ICs) for a broad range of applications. Silicon Laboratories diverse portfolio of highly integrated, patented solutions is developed by a world-class engineering team with expertise in cutting-edge mixed-signal design. The company has design, engineering, marketing, sales and applications offices throughout North America, Europe and Asia. For more information about Silicon Laboratories, please visit www.silabs.com.
Forward Looking Statements
This press release contains forward-looking statements based on Silicon Laboratories current expectations. The words believe, estimate, expect, intend, anticipate, plan, project, will and similar phrases as they relate to Silicon Laboratories are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Laboratories and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Laboratories may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; volatile stock price; average selling prices of products may decrease significantly and rapidly, dependence on a limited number of products and customers; difficulties developing new products that achieve market acceptance; risks that Silicon Laboratories may not be able to manage strains associated with its growth (including risks associated with the implementation of its enterprise resource planning system); dependence on key personnel; difficulties managing our manufacturers and subcontractors; difficulties managing international activities; credit risks associated with our accounts receivable;
geographic concentration of manufacturers, assemblers, test service providers and customers in the Pacific Rim that subjects Silicon Laboratories business and results of operations to risks of natural disasters, epidemics, war and political unrest; product development risks; inventory-related risks; intellectual property litigation risks; risks associated with acquisitions and divestitures; the competitive and cyclical nature of the semiconductor industry and other factors that are detailed in Silicon Laboratories filings with the SEC. Silicon Laboratories disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Note to editors: Silicon Laboratories, Silicon Labs and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Silicon Laboratories Inc., Shannon Pleasant, (512) 464 9254, shannon.pleasant@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
June 30, |
|
July 1, |
|
June 30, |
|
July 1, |
|
||||
Revenues |
|
$ |
75,597 |
|
$ |
73,936 |
|
$ |
149,411 |
|
$ |
140,588 |
|
Cost of revenues |
|
30,233 |
|
24,442 |
|
58,672 |
|
45,569 |
|
||||
Gross profit |
|
45,364 |
|
49,494 |
|
90,739 |
|
95,019 |
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
22,145 |
|
22,619 |
|
46,952 |
|
43,688 |
|
||||
Selling, general and administrative |
|
21,282 |
|
22,822 |
|
45,574 |
|
43,552 |
|
||||
In-process research and development |
|
|
|
2,600 |
|
|
|
2,600 |
|
||||
Operating expenses |
|
43,427 |
|
48,041 |
|
92,526 |
|
89,840 |
|
||||
Operating income (loss) |
|
1,937 |
|
1,453 |
|
(1,787 |
) |
5,179 |
|
||||
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
Interest income |
|
7,032 |
|
3,624 |
|
10,867 |
|
6,826 |
|
||||
Interest expense |
|
(167 |
) |
(225 |
) |
(398 |
) |
(400 |
) |
||||
Other income (expense), net |
|
(51 |
) |
45 |
|
(170 |
) |
291 |
|
||||
Income from continuing operations before income taxes |
|
8,751 |
|
4,897 |
|
8,512 |
|
11,896 |
|
||||
Provision for income taxes |
|
1,859 |
|
1,892 |
|
2,366 |
|
3,693 |
|
||||
Income from continuing operations |
|
6,892 |
|
3,005 |
|
6,146 |
|
8,203 |
|
||||
Income from discontinued operations, net of income taxes |
|
581 |
|
7,132 |
|
156,940 |
|
12,998 |
|
||||
Net income |
|
$ |
7,473 |
|
$ |
10,137 |
|
$ |
163,086 |
|
$ |
21,201 |
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
||||
Income from continuing operations |
|
$ |
0.13 |
|
$ |
0.05 |
|
$ |
0.11 |
|
$ |
0.15 |
|
Net income |
|
$ |
0.14 |
|
$ |
0.18 |
|
$ |
2.97 |
|
$ |
0.38 |
|
|
|
|
|
|
|
|
|
|
|
||||
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
||||
Income from continuing operations |
|
$ |
0.12 |
|
$ |
0.05 |
|
$ |
0.11 |
|
$ |
0.14 |
|
Net income |
|
$ |
0.13 |
|
$ |
0.18 |
|
$ |
2.90 |
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted-average common shares outstanding: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
54,901 |
|
55,842 |
|
54,856 |
|
55,460 |
|
||||
Diluted |
|
56,312 |
|
57,858 |
|
56,308 |
|
57,761 |
|
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
|
Three Months |
|
||
|
|
June 30, |
|
|
GAAP operating income |
|
$ |
1,937 |
|
Stock compensation adjustments: |
|
|
|
|
Cost of revenues |
|
379 |
|
|
Research and development |
|
4,078 |
|
|
Selling, general and administrative |
|
4,164 |
|
|
Non-GAAP operating income |
|
$ |
10,558 |
|
|
|
|
|
|
Non-GAAP operating income % |
|
14.0 |
% |
|
Three Months Ended |
|
|||||
|
|
June 30, |
|
March 31, |
|
||
GAAP income (loss) from continuing operations |
|
$ |
6,892 |
|
$ |
(746 |
) |
Stock compensation adjustments: |
|
|
|
|
|
||
Cost of revenues |
|
379 |
|
307 |
|
||
Research and development |
|
4,078 |
|
5,371 |
|
||
Selling, general and administrative |
|
4,164 |
|
6,092 |
|
||
Provision for income taxes |
|
(1,137 |
) |
(2,068 |
) |
||
Non-GAAP income from continuing operations |
|
$ |
14,376 |
|
$ |
8,956 |
|
|
|
|
|
|
|
||
GAAP diluted shares outstanding |
|
56,312 |
|
54,806 |
|
||
Stock options and awards |
|
|
|
1,505 |
|
||
Non-GAAP diluted shares outstanding |
|
56,312 |
|
56,311 |
|
||
Non-GAAP diluted earnings per share from continuing operations |
|
$ |
0.26 |
|
$ |
0.16 |
|
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
|
|
June 30, |
|
December 30, |
|
||
Assets |
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
162,066 |
|
$ |
68,188 |
|
Short-term investments |
|
481,930 |
|
318,104 |
|
||
Accounts receivable, net of allowance for doubtful accounts of $501 at June 30, 2007 and $421 at December 30, 2006 |
|
42,171 |
|
36,657 |
|
||
Inventories |
|
18,982 |
|
22,016 |
|
||
Deferred income taxes |
|
5,229 |
|
12,118 |
|
||
Prepaid expenses and other |
|
31,989 |
|
12,944 |
|
||
Current assets of discontinued operations |
|
|
|
33,680 |
|
||
Total current assets |
|
742,367 |
|
503,707 |
|
||
Property, equipment and software, net |
|
29,824 |
|
34,070 |
|
||
Goodwill |
|
65,519 |
|
65,680 |
|
||
Other intangible assets, net |
|
18,109 |
|
20,271 |
|
||
Other assets, net |
|
24,070 |
|
24,528 |
|
||
Non-current assets of discontinued operations |
|
|
|
38,739 |
|
||
Total assets |
|
$ |
879,889 |
|
$ |
686,995 |
|
|
|
|
|
|
|
||
Liabilities and Stockholders Equity |
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
||
Accounts payable |
|
$ |
30,051 |
|
$ |
26,438 |
|
Accrued expenses |
|
18,148 |
|
23,051 |
|
||
Deferred income on shipments to distributors |
|
18,341 |
|
20,568 |
|
||
Income taxes |
|
|
|
15,063 |
|
||
Current liabilities of discontinued operations |
|
10,099 |
|
16,502 |
|
||
Total current liabilities |
|
76,639 |
|
101,622 |
|
||
Long-term obligations and other liabilities |
|
49,641 |
|
15,641 |
|
||
Non-current liabilities of discontinued operations |
|
|
|
1,050 |
|
||
Total liabilities |
|
126,280 |
|
118,313 |
|
||
|
|
|
|
|
|
||
Commitments and contingencies |
|
|
|
|
|
||
|
|
|
|
|
|
||
Stockholders equity: |
|
|
|
|
|
||
Preferred stock$0.0001 par value; 10,000 shares authorized; no shares issued and outstanding |
|
|
|
|
|
||
Common stock$0.0001 par value; 250,000 shares authorized; 55,114 and 54,802 shares issued and outstanding at June 30, 2007 and December 30, 2006, respectively |
|
6 |
|
5 |
|
||
Additional paid-in capital |
|
395,495 |
|
373,655 |
|
||
Retained earnings |
|
358,108 |
|
195,022 |
|
||
Total stockholders equity |
|
753,609 |
|
568,682 |
|
||
Total liabilities and stockholders equity |
|
$ |
879,889 |
|
$ |
686,995 |
|
# # #